Home » Enzon to Sell Specialty Business to Sigma-Tau
Enzon to Sell Specialty Business to Sigma-Tau
Enzon Pharmaceuticals, Inc. announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group
for $300 million plus an additional amount of up to $27 million based on success milestones.
RTTNews
RTTNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May